A
Arnab Chatterjee
Researcher at Tata Consultancy Services
Publications - 165
Citations - 5916
Arnab Chatterjee is an academic researcher from Tata Consultancy Services. The author has contributed to research in topics: Population & Kinetic exchange models of markets. The author has an hindex of 34, co-authored 142 publications receiving 5149 citations. Previous affiliations of Arnab Chatterjee include Saha Institute of Nuclear Physics & Aalto University.
Papers
More filters
Journal ArticleDOI
Small-world properties of the Indian railway network.
TL;DR: Rigorous analysis of the existing data shows that the Indian railway network displays small-world properties and several other quantities associated with this network are defined and estimated.
Journal ArticleDOI
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
David Plouffe,Achim Brinker,Case W. McNamara,Kerstin Henson,Nobutaka Kato,Kelli Kuhen,Advait Nagle,Francisco Adrian,Jason T. Matzen,Paul A. Anderson,Tae-gyu Nam,Nathanael S. Gray,Arnab Chatterjee,Jeff Janes,S. Frank Yan,Richard E. Trager,Jeremy S. Caldwell,Peter G. Schultz,Yingyao Zhou,Elizabeth A. Winzeler +19 more
TL;DR: An efficient and robust high-throughput cell-based screen based on proliferation of Plasmodium falciparum in erythrocytes, which identified most known antimalarials and many novel chemical scaffolds, which likely act through both known and novel pathways.
Journal ArticleDOI
Pareto law in a kinetic model of market with random saving propensity
TL;DR: In this article, the authors have numerically simulated the ideal-gas models of trading markets, where each agent is identified with a gas molecule and each trading as an elastic or money-conserving two-body collision.
Journal ArticleDOI
Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
Michael B. Harbut,Catherine Vilchèze,Xiaozhou Luo,Mary E. Hensler,Hui Guo,Baiyuan Yang,Arnab Chatterjee,Victor Nizet,William R. Jacobs,Peter G. Schultz,Feng Wang +10 more
TL;DR: The results suggest that the thioredoxin-mediated redox cascade of Gram-positive pathogens is a valid target for the development of antibacterial drugs, and that the existing clinical agent auranofin may be repurposed to aid in the treatment of several important antibiotic-resistant pathogens.